Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil

NCT04948411 · clinicaltrials.gov ↗

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Sponsor

Latin American Cooperative Oncology Group